HOXD9 and cancer: Furthermore, immunohistochemical studies showed no apparent correlation between HOXD9 expression level and WHO grade or MIB-1 index, suggesting that HOXD9 may be expressed in primitive cancer cell populations, including GCSCs in vivo.